← FDA Drug Approvals (Drugs@FDA)
SORAFENIB TOSYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2025-01-27
Drug application
- FDA Application #
ANDA212228- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SORAFENIB TOSYLATE
- Generic name
- Sorafenib Tosylate
- Active ingredients
- SORAFENIB TOSYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2025-01-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown